Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms (Q34021151)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms |
scientific article |
Statements
1 reference
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms (English)
1 reference
Hagop Kantarjian
1 reference
Srdan Verstovsek
1 reference
Peggy A Scherle
1 reference
Taghi Manshouri
1 reference
Jordan S Fridman
1 reference
Kris Vaddi
1 reference
Alfonso Quintás-Cardama
1 reference
Phillip Liu
1 reference
Jun Li
1 reference
Eian Caulder
1 reference
Xiaoming Wen
1 reference
Yanlong Li
1 reference
Paul Waeltz
1 reference
Mark Rupar
1 reference
Timothy Burn
1 reference
Yvonne Lo
1 reference
Jennifer Kelley
1 reference
Maryanne Covington
1 reference
Stacey Shepard
1 reference
James D Rodgers
1 reference
Patrick Haley
1 reference
3 February 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference